Clinical Study

Serum Amyloid A Level in Egyptian Children with Familial Mediterranean Fever

Table 2

Laboratory findings of studied FMF patients at the time of study.

VariableRangeMean ± SD

Hemoglobin (gm/dL)10.1–13.9 (71)12.3 ± 0.9
Total leucocytic count (×1000/µL)3.8–23.4 (71)7.7 ± 3.2
Platelet count (×1000/µL)134–523 (71)317 ± 78.2
ESR (mm/hr)
 <153–14 (21/71, 29.6%)9.6 ± 3.4
 ≥1515–90 (50/71, 70.4%)38.1 ± 16.7
CRP Titer
 Positive2.4–48 (22/71, 31%)15.4 ± 12.8
 Negative0 (49/71, 69.0%)
Serum amyloid A (SAA) (mg/L)
 <30 mg/L13.7–29.5 (15/71, 21.1%)24.8 ± 4.8
 ≥30 mg/L32.6–129.2 (56/71, 78.9%)81.62 ± 31.6

Number in parentheses is number of patients.
Only 5 patients (7%) had TLC 13.7–23.4 × 103 per microliter of blood.
The median SAA level was 76.1 mg/L (for the range 13.7–129.2 mg/L).